Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer.

Suppr

超能文献

作者信息

Knoll J, Ecseri Z, Kelemen K, Nievel J, Knoll B

出版信息

Arch Int Pharmacodyn Ther. 1965 May;155(1):154-64.

PMID:4378644

Abstract

摘要

相似文献

Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer.

Arch Int Pharmacodyn Ther. 1965 May;155(1):154-64.

The effect of psychopharmaca on exteroceptive blood pressure reflexes in non-anaesthetized cats.精神药物对未麻醉猫的外感受性血压反射的影响。

Arch Int Pharmacodyn Ther. 1966 Jan;159(1):61-9.

Pharmacological properties of Su-19789B, a unique central nervous system stimulant.

Arch Int Pharmacodyn Ther. 1970 Mar;184(1):34-44.

Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration.

Pharmacol Biochem Behav. 1997 Jan;56(1):9-14. doi: 10.1016/S0091-3057(96)00123-2.

[Psychopharmacological agents and taste].

Monatsschr Ohrenheilkd Laryngorhinol. 1968;102(4):230-1.

Neuropharmacological profile of MD 780515, a new reversible inhibitor of type A monoamine oxidase.新型A型单胺氧化酶可逆抑制剂MD 780515的神经药理学特征

Arch Int Pharmacodyn Ther. 1982 Oct;259(2):194-221.

Flurothyl in mice: seizure, post-convulsive behavior, and interactions with psychotropic drugs.

Can J Physiol Pharmacol. 1968 Jan;46(1):93-100. doi: 10.1139/y68-016.

Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.

Proc West Pharmacol Soc. 1966;9:6-8.

Effect of pretreatment with monoamine oxidase inhibitors or (+)-amphetamine on leptazol convulsions in mice and rats.

J Pharm Pharmacol. 1968 Dec;20:Suppl:122S+. doi: 10.1111/j.2042-7158.1968.tb09872.x.

The effects of monoamine oxidase inhibitors on spinal synaptic activity.单胺氧化酶抑制剂对脊髓突触活动的影响。

J Pharmacol Exp Ther. 1967 Dec;158(3):405-15.

引用本文的文献

L-DOPA-therapy in Parkinson's disease: some personal reflections on L-DOPA therapy from Vienna and Berlin.左旋多巴治疗帕金森病：来自维也纳和柏林的关于左旋多巴治疗的一些个人思考。

J Neural Transm (Vienna). 2023 Nov;130(11):1323-1335. doi: 10.1007/s00702-023-02692-9. Epub 2023 Oct 5.

Deprenyl reduces inflammation during acute SIV infection.司来吉兰可减轻急性SIV感染期间的炎症反应。

iScience. 2022 Apr 6;25(5):104207. doi: 10.1016/j.isci.2022.104207. eCollection 2022 May 20.

Revisiting the Role of Astrocytic MAOB in Parkinson's Disease.重新审视星形胶质细胞 MAOB 在帕金森病中的作用。

Int J Mol Sci. 2022 Apr 18;23(8):4453. doi: 10.3390/ijms23084453.

The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.重度抑郁症的细胞和分子基础：为理解临床抑郁症建立一个统一的模型。

Mol Biol Rep. 2020 Jan;47(1):753-770. doi: 10.1007/s11033-019-05129-3. Epub 2019 Oct 14.

Selegiline: a molecule with innovative potential.司来吉兰：一种具有创新潜力的分子。

J Neural Transm (Vienna). 2020 May;127(5):831-842. doi: 10.1007/s00702-019-02082-0. Epub 2019 Sep 27.

Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson's disease.MAO-B 和 COMT 抑制剂：对大脑多巴胺水平的影响及其在帕金森病中的应用。

J Neural Transm (Vienna). 2019 Apr;126(4):433-448. doi: 10.1007/s00702-018-1952-7. Epub 2018 Nov 1.

Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease.不可逆 MAO-B 抑制剂司来吉兰和雷沙吉兰在帕金森病中的神经保护作用的药理学方面。

J Neural Transm (Vienna). 2018 Nov;125(11):1735-1749. doi: 10.1007/s00702-018-1853-9. Epub 2018 Feb 7.

Effects on Sperms' Quality of Selegiline in Aged Rats.司来吉兰对老年大鼠精子质量的影响。

Open Med Chem J. 2017 Nov 30;11:138-145. doi: 10.2174/1874104501711010138. eCollection 2017.

The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015).司来吉兰/(-)-丙炔苯丙胺在研究和治疗中的 50 年意义 (1965-2015)。

Mol Psychiatry. 2016 Nov;21(11):1499-1503. doi: 10.1038/mp.2016.127. Epub 2016 Aug 2.

MAO-inhibitors in Parkinson's Disease.MAO 抑制剂在帕金森病中的应用。

Exp Neurobiol. 2011 Mar;20(1):1-17. doi: 10.5607/en.2011.20.1.1. Epub 2011 Mar 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验